Gene Expression Analyses Implicate an Alternative Splicing Program in Regulating Contractile Gene Expression and Serum Response Factor Activity in Mice

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Dasgupta, Twishasri ^a   Stillwagon, Samantha J ^a   Ladd, Andrea N ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CUG BP ELAV LIKE PROTEIN; HU ANTIGEN; SERUM RESPONSE FACTOR; UNCLASSIFIED DRUG;

ACTA1 GENE; ALTERNATIVE RNA SPLICING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CASQ1 GENE; CELF1 GENE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; CTGF GENE; EGR1 GENE; FEMALE; FHL1 GENE; FHL2 GENE; FOS GENE; GENE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE TARGETING; HEART CONTRACTION; HEART FAILURE; HOPX GENE; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NPPB GENE; NUCLEOTIDE SEQUENCE; PHENOTYPE; RCAN1 GENE; SRF GENE; TPM2 GENE; TRANSCRIPTION REGULATION;

ALTERNATIVE SPLICING; ANIMALS; CALCIUM SIGNALING; CCAAT-ENHANCER-BINDING PROTEIN-DELTA; GENE EXPRESSION REGULATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MICE; MICE, TRANSGENIC; MYOCARDIAL CONTRACTION; MYOCARDIUM; SERUM RESPONSE FACTOR; SIGNAL TRANSDUCTION; VENTRICULAR MYOSINS;

EID: 84874253505     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0056590     Document Type: Article

References (40)

1. Pan Q, Shai O, Lee LJ, Frey BJ, Blencowe BJ, (2008) Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat Genet 40: 1413-1415.
2. Wang ET, Sandberg R, Luo S, Khrebtukova I, Zhang L, et al. (2008) Alternative isoform regulation in human tissue transcriptomes. Nature 456: 470-476.
3. Ward AJ, Cooper TA, (2010) The pathobiology of splicing. J Pathol 220: 152-163.
4. Kong SW, Hu YW, Ho JW, Ikeda S, Polster S, et al. (2010) Heart failure-associated changes in RNA splicing of sarcomere genes. Circ Cardiovasc Genet 3: 138-146.
5. Park JY, Li W, Zheng D, Zhai P, Zhao Y, et al. (2011) Comparative analysis of mRNA isoform expression in cardiac hypertrophy and development reveals multiple post-transcriptional regulatory modules. PLoS One 6: e22391.
6. Song HK, Hong SE, Kim T, Kim do H, (2012) Deep RNA sequencing reveals novel cardiac transcriptomic signatures for physiological and pathological hypertrophy. PLoS One 7: e35552.
7. Komamura K, Iwai N, Kokame K, Yasumura Y, Kim J, et al. (2004) The role of a common TNNT2 polymorphism in cardiac hypertrophy. J Hum Genet 49: 129-133.
8. Mango R, Biocca S, del Vecchio F, Clementi F, Sangiuolo F, et al. (2005) In vivo and in vitro studies support that a new splicing isoform of OLR1 gene is protective against acute myocardial infarction. Circ Res 97: 152-158.
9. Dasgupta T, Ladd AN, (2012) The importance of CELF control: molecular and biological roles of the CUG-BP, Elav-like family of RNA-binding proteins. WIREs RNA 3: 104-121.
10. Ladd A, Taffet G, Hartley C, Kearney D, Cooper T, (2005) Cardiac-specific repression of CELF activity disrupts alternative splicing and causes cardiomyopathy. Mol Cell Biol 25: 6267-6278.
11. Terenzi F, Brimacombe KR, Penn MS, Ladd AN, (2009) CELF-mediated alternative splicing is required for cardiac function during early, but not later, postnatal life. J Mol Cell Cardiol 46: 395-404.
12. Philippar U, Schratt G, Dieterich C, Muller JM, Galgoczy P, et al. (2004) The SRF target gene Fhl2 antagonizes RhoA/MAL-dependent activation of SRF. Mol Cell 16: 867-880.
13. Yamaguchi S, Asanoma K, Takao T, Kato K, Wake N, (2009) Homeobox gene HOPX is epigenetically silenced in human uterine endometrial cancer and suppresses estrogen-stimulated proliferation of cancer cells by inhibiting serum response factor. Int J Cancer 124: 2577-2588.
14. Ho TH, Bundman D, Armstrong DL, Cooper TA, (2005) Transgenic mice expressing CUG-BP1 reproduce splicing mis-regulation observed in myotonic dystrophy. Hum Mol Genet 14: 1539-1547.
15. Edgar R, Domrachev M, Lash AE, (2002) Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nuc Acids Res 30: 207-210.
16. Smyth GK, (2004) Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Statistical applications in genetics and molecular biology 3: Article3.
17. Zheng Q, Wang XJ, (2008) GOEAST: a web-based software toolkit for Gene Ontology enrichment analysis. Nuc Acids Res 36: W358-363.
18. Ladd A, Charlet-B N, Cooper T, (2001) The CELF family of RNA binding proteins is implicated in cell-specific and developmentally regulated alternative splicing. Mol Cell Biol 21: 1285-1296.
19. Kalsotra A, Xiao X, Ward AJ, Castle JC, Johnson JM, et al. (2008) A postnatal switch of CELF and MBNL proteins reprograms alternative splicing in the developing heart. Proc Natl Acad Sci U S A 105: 20333-20338.
20. Ding J-H, Xu X, Yang D, Chu P-H, Dalton N, et al. (2004) Dilated cardiomyopathy caused by tissue-specific ablation of SC35 in heart. EMBO J 23: 885-896.
21. Xu X, Yang D, Ding JH, Wang W, Chu PH, et al. (2005) ASF/SF2-regulated CaMKIIdelta alternative splicing temporally reprograms excitation-contraction coupling in cardiac muscle. Cell 120: 59-72.
22. Chen F, Kook H, Milewski R, Gitler AD, Lu MM, et al. (2002) Hop is an unusual homeobox gene that modulates cardiac development. Cell 110: 713-723.
23. Shin CH, Liu ZP, Passier R, Zhang CL, Wang DZ, et al. (2002) Modulation of cardiac growth and development by HOP, an unusual homeodomain protein. Cell 110: 725-735.
24. Balza RO Jr, Misra RP, (2006) Role of the serum response factor in regulating contractile apparatus gene expression and sarcomeric integrity in cardiomyocytes. J Biol Chem 281: 6498-6510.
25. Cunha SR, Bhasin N, Mohler PJ, (2007) Targeting and stability of Na/Ca exchanger 1 in cardiomyocytes requires direct interaction with the membrane adaptor ankyrin-B. J Biol Chem 282: 4875-4883.
26. Mohler PJ, Le Scouarnec S, Denjoy I, Lowe JS, Guicheney P, et al. (2007) Defining the cellular phenotype of "ankyrin-B syndrome" variants: human ANK2 variants associated with clinical phenotypes display a spectrum of activities in cardiomyocytes. Circulation 115: 432-441.
27. Mohler PJ, Schott JJ, Gramolini AO, Dilly KW, Guatimosim S, et al. (2003) Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death. Nature 421: 634-639.
28. Mohler PJ, Splawski I, Napolitano C, Bottelli G, Sharpe L, et al. (2004) A cardiac arrhythmia syndrome caused by loss of ankyrin-B function. Proc Natl Acad Sci U S A 101: 9137-9142.
29. Treisman R, Ammerer G, (1992) The SRF and MCM1 transcription factors. Curr Opin Genet Dev 2: 221-226.
30. Nelson TJ, Balza R Jr, Xiao Q, Misra RP, (2005) SRF-dependent gene expression in isolated cardiomyocytes: regulation of genes involved in cardiac hypertrophy. J Mol Cell Cardiol 39: 479-489.
31. Zhang X, Azhar G, Chai J, Sheridan P, Nagano K, et al. (2001) Cardiomyopathy in transgenic mice with cardiac-specific overexpression of serum response factor. Amer J Physiol Heart Circ Physiol 280: H1782-1792.
32. Zhang X, Azhar G, Furr MC, Zhong Y, Wei JY, (2003) Model of functional cardiac aging: young adult mice with mild overexpression of serum response factor. Amer J Physiol Regul Integr Comp Physiol 285: R552-560.
33. Miano JM, (2010) Role of serum response factor in the pathogenesis of disease. Lab Invest 90: 1274-1284.
34. Akazawa H, Komuro I, (2003) Roles of cardiac transcription factors in cardiac hypertrophy. Circ Res 92: 1079-1088.
35. Kong Y, Shelton JM, Rothermel B, Li X, Richardson JA, et al. (2001) Cardiac-specific LIM protein FHL2 modifies the hypertrophic response to beta-adrenergic stimulation. Circulation 103: 2731-2738.
36. Bovill E, Westaby S, Crisp A, Jacobs S, Shaw T, (2009) Reduction of four-and-a-half LIM-protein 2 expression occurs in human left ventricular failure and leads to altered localization and reduced activity of metabolic enzymes. J Thorac Cardiovasc Surg 137: 853-861.
37. Trivedi CM, Cappola TP, Margulies KB, Epstein JA, (2011) Homeodomain only protein x is down-regulated in human heart failure. J Mol Cell Cardiol 50: 1056-1058.
38. Aronow BJ, Toyokawa T, Canning A, Haghighi K, Delling U, et al. (2001) Divergent transcriptional responses to independent genetic causes of cardiac hypertrophy. Physiol Genom 6: 19-28.
39. Stamm S, Ben-Ari S, Rafalska I, Tang Y, Zhang Z, et al. (2005) Function of alternative splicing. Gene 344: 1-20.
40. McGlincy NJ, Smith CW, (2008) Alternative splicing resulting in nonsense-mediated mRNA decay: what is the meaning of nonsense? Trends Biochem Sci 33: 385-393.